Tested Applications
| Positive WB detected in | mouse brain tissue, mouse kidney tissue, mouse small intestine tissue |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
21628-1-AP targets SLC5A3 in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag16218 Product name: Recombinant human SLC5A3 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 533-695 aa of BC146536 Sequence: TPPPTKEQIRTTTFWSKKNLVVKENCSPKEEPYQMQEKSILRCSENNETINHIIPNGKSEDSIKGLQPEDVNLLVTCREEGNPVASLGHSEAETPVDAYSNGQAALMGEKERKKETDDGGRYWKFIDWFCGFKSKSLSKRSLRDLMEEEAVCLQMLEETRQVK Predict reactive species |
| Full Name | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
| Calculated Molecular Weight | 718 aa, 80 kDa |
| Observed Molecular Weight | 77 kDa |
| GenBank Accession Number | BC146536 |
| Gene Symbol | SLC5A3 |
| Gene ID (NCBI) | 6526 |
| RRID | AB_10863123 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P53794 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Publications
What published studies show
The SLC5A3 Polyclonal antibody (Cat# 21628-1-AP) has 4 citations. These appear in Nature Cancer, Frontiers in Cell and Developmental Biology, Discovery Oncology, and PLoS One. The associated research fields span cancer biology—including solid tumor therapy via endoplasmic reticulum stress, osteosarcoma prognostic signatures, and melanoma survival/immunotherapy modeling—as well as hematology, where SLC5A3 was examined in METTL16-mediated m6A modification in haemoglobin H disease. Applications cited include Western blot, immunohistochemistry, and immunofluorescence in human samples.
| Species | Application | Title |
|---|---|---|
Nat Cancer Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress | ||
Front Cell Dev Biol Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma | ||
Discov Oncol Development and validation of a prognostic model for predicting survival and immunotherapy benefits in melanoma based on metabolism-relevant genes | ||





